| Systematic (IUPAC) name | |
|---|---|
| (6aR)-3-(6-bromohex-2-ynyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 10549140 |
| ChemSpider | 26001356 |
| Chemical data | |
| Formula | C22H27BrO2 |
| Mol. mass | 403.352 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
O-806 is a drug which is a cannabinoid derivative that is used in scientific research. It is described as a mixed agonist/antagonist at the cannabinoid receptor CB1, meaning that it acts as an antagonist when co-administered alongside a more potent CB1 agonist, but exhibits weak partial agonist effects when administered by itself.[1][2]
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| This article about a cannabinoid is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)